Correction
A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial (vol 261, pg 2101, 2014)
Fecha
2015Registro en:
0340-5354
10.1007/s00415-014-7565-7
Autor
Ziemssen, T
Bajenaru, OA
Carra, A
de Klippel, N
de Sa, JC
Edland, A
Frederiksen, JL
Heinzlef, O
Karageorgiou, KE
Delgado, RHL
Landtblom, AM
Islas, MAM
Tubridy, N
Gilgun-Sherki, Y